Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 431

1.

Microtubule-interacting drugs induce moderate and reversible damage to human bone marrow mesenchymal stem cells.

Polioudaki H, Kastrinaki MC, Papadaki HA, Theodoropoulos PA.

Cell Prolif. 2009 Aug;42(4):434-47. doi: 10.1111/j.1365-2184.2009.00607.x. Epub 2009 May 22.

PMID:
19486015
2.

[Antimicrotubule agents can activate different apoptotic pathways].

Kisurina-Evgen'eva OP, Briantseva SA, Stil' AA, Onishchenko GE.

Biofizika. 2006 Sep-Oct;51(5):875-9. Russian.

PMID:
17131827
3.

Presence of mesenchymal stem cells in human bone marrow after exposure to chemotherapy: evidence of resistance to apoptosis induction.

Mueller LP, Luetzkendorf J, Mueller T, Reichelt K, Simon H, Schmoll HJ.

Stem Cells. 2006 Dec;24(12):2753-65. Epub 2006 Aug 24.

4.

Opposite effects of microtubule-stabilizing and microtubule-destabilizing drugs on biogenesis of mitochondria in mammalian cells.

Karbowski M, Spodnik JH, Teranishi M, Wozniak M, Nishizawa Y, Usukura J, Wakabayashi T.

J Cell Sci. 2001 Jan;114(Pt 2):281-91.

5.

Effects of anti-inflammatory drugs on proliferation, cytotoxicity and osteogenesis in bone marrow mesenchymal stem cells.

Chang JK, Li CJ, Wu SC, Yeh CH, Chen CH, Fu YC, Wang GJ, Ho ML.

Biochem Pharmacol. 2007 Nov 1;74(9):1371-82. Epub 2007 Jul 7.

PMID:
17714695
6.

The flavonoid quercetin transiently inhibits the activity of taxol and nocodazole through interference with the cell cycle.

Samuel T, Fadlalla K, Turner T, Yehualaeshet TE.

Nutr Cancer. 2010;62(8):1025-35. doi: 10.1080/01635581.2010.492087.

7.
8.

Simulated microgravity inhibits the proliferation and osteogenesis of rat bone marrow mesenchymal stem cells.

Dai ZQ, Wang R, Ling SK, Wan YM, Li YH.

Cell Prolif. 2007 Oct;40(5):671-84. Erratum in: Cell Prolif. 2008 Apr;41(2):375.

PMID:
17877609
9.

Signaling and biological effects of glucagon-like peptide 1 on the differentiation of mesenchymal stem cells from human bone marrow.

Sanz C, Vázquez P, Blázquez C, Barrio PA, Alvarez Mdel M, Blázquez E.

Am J Physiol Endocrinol Metab. 2010 Mar;298(3):E634-43. doi: 10.1152/ajpendo.00460.2009. Epub 2009 Dec 29.

PMID:
20040695
10.

Biological properties of jatrophane polyesters, new microtubule-interacting agents.

Miglietta A, Gabriel L, Appendino G, Bocca C.

Cancer Chemother Pharmacol. 2003 Jan;51(1):67-74. Epub 2002 Nov 20.

PMID:
12497208
11.
12.

The effects of taxol on the organization of the cytoskeleton in cultured ovarian granulosa cells.

Herman B, Langevin MA, Albertini DF.

Eur J Cell Biol. 1983 Jul;31(1):34-45.

PMID:
6137363
13.

Adipogenic effect of alcohol on human bone marrow-derived mesenchymal stem cells.

Wezeman FH, Gong Z.

Alcohol Clin Exp Res. 2004 Jul;28(7):1091-101.

PMID:
15252296
14.

[Safety evaluation of tissue engineered medical devices using normal human mesenchymal stem cells].

Sawada R, Ito T, Tsuchiya T.

Yakugaku Zasshi. 2007 May;127(5):851-6. Review. Japanese.

16.

Length of mitotic arrest induced by microtubule-stabilizing drugs determines cell death after mitotic exit.

Bekier ME, Fischbach R, Lee J, Taylor WR.

Mol Cancer Ther. 2009 Jun;8(6):1646-54. doi: 10.1158/1535-7163.MCT-08-1084. Epub 2009 Jun 9.

17.
18.

Microtubule-damaging agents enhance RASSF1A-induced cell death in lung cancer cell lines.

Whang YM, Park KH, Jung HY, Jo UH, Kim YH.

Cancer. 2009 Mar 15;115(6):1253-66. doi: 10.1002/cncr.24113.

19.

Characterization of nuclear betaII-tubulin in tumor cells: a possible novel target for taxol.

Xu K, Ludueña RF.

Cell Motil Cytoskeleton. 2002 Sep;53(1):39-52.

PMID:
12211114
20.

[Study on differentiation of human mesenchymal stem cells into epidermal cells].

Wang SY, Han CM, Lai PP, Cen HH.

Zhonghua Shao Shang Za Zhi. 2007 Feb;23(1):66-8. Chinese.

PMID:
17605261

Supplemental Content

Support Center